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Once the EC Directive 96/29 has been implemented into national regulation across Europe, the coordination of dosimetry
laboratories for the monitoring of occupational exposures becomes the principal aim to achieve. Within this framework the
European Radiation Dosimetry Group, EURADOS, carried out an Action on ‘Harmonisation of Individual Monitoring’
(2000–2004) to promote coordination in the field of individual monitoring of occupational exposures throughout Europe. With
reference to internal exposures, the main aims were the completion of a catalogue of internal dosimetry services and an
inventory of methods and techniques used for individual monitoring at European internal dosimetry facilities. At the end of
this EURADOS Action, a report was published in Radiation Protection Dosimetry in 2004. The information collected related
to various topics: the equipments used for the measurement of internal exposures, calibration and sensitivity data, the methods
applied for the assessment of internal doses, Quality Control procedures, Quality Assurance Programmes in the facilities and
legal requirements. The information to be presented here will give a general overview of the actual status of individual
monitoring for internal exposures in Europe.
INTRODUCTION
One of the issues addressed in the Euratom Council
Directive 96/29 of 13 May 1996(1) is that monitoring
of the exposure should in general be performed
by approved dosimetric services, but the Directive
gives no criteria for the approval of these services.
There is, however, a consensus among professionals
that approved dosimetric services should perform
in agreement with the relevant international
standards [e.g. ISO (International Organisation for
Standarisation) and IEC (International Electro-
technical Commission)] and recommendations
(e.g. from the European Commission and the Inter-
national Atomic Energy Agency).
The European Radiation Dosimetry Group,
EURADOS, was created to be a scientific network
of European laboratories (voting members) and
Associated Members involved in scientific research
in radiation dosimetry. Over the past 10 years
emphasis has been put on the harmonisation of
individual monitoring procedures in Europe. A
working group funded by the European Commission
in the 5th framework programme (2001–2004) was
established within the Concerted Action ‘Dosimetry
Network’. Experts from EU member states aimed
at assisting in the process of harmonisation of
individual monitoring of internal and external
exposures as part of the protection of occupationally
exposed persons. In this instance the term harmon-
isation does not mean that the services have to
follow exactly the same procedures but aim to meet
the same requirements and as a consequence their
results should be comparable.
One of the tasks of this Harmonisation Group was
to study the integration of dosimetric methods for
internal and external exposures. A subgroup of dosi-
metry scientists investigated how the results from
personal dosemeters for external radiation, from
workplace monitoring and from monitoring for
internal exposure can be combined into a complete
and consistent system of individual monitoring.
A Dosimetry Network of 28 countries working
together for harmonisation has been established.
Important information about the performance of
European dosimetric services has been collected,
with the help of the contact-persons (one per
country), who have actively collaborated with
EURADOS in the distribution of Questionnaires
among the individual monitoring facilities of each
European country.Corresponding author: ma.lopez@ciemat.es
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INDIVIDUAL MONITORING OF INTERNAL
EXPOSURES: EUROPEAN CATALOGUE OF
METHODS AND SERVICES
One of the objectives of the EURADOS study was
the completion of a catalogue of techniques and
an inventory of methods applied at the internal
dosimetry laboratories throughout Europe. The
‘Eurados 2002 Questionnaire(2)’ was sent to services,
requesting information about the equipments used
for the measurement of the retained/excreted/air
concentration activity of radionuclides internally
deposited in the body, and the methodology, avail-
able tools and legal requirements associated with
the assessment of internal doses.
Seventy-three completed questionnaires were
returned by e-mail from the internal dosimetry facilities
of 26 countries. At the end of this EURADOS Action,
a report was submitted for publication(2). This report
presents an important overview of the individual
monitoring of internal exposures in Europe for
workers with the risk of intake of radionuclides.
The Internal Dosimetry Catalogue contains all the
materials collected from the services which completed
the EURADOS questionnaire. This broad set of data
includes information from techniques to perform-
ance criteria used in facilities dealing with the assess-
ment of internal exposures. The interest was mainly
focused on equipment, calibration procedures, sens-
itivity [minimum detectable activity (MDA) of the
radionuclides of interest] and the methodology
applied for the evaluation of effective doses. Refer-
ence levels, dosimetric tools, application of the latest
International Commission on Radiation Protection
(ICRP) biokinetic models and Quality Assurance of
laboratories were also reported.
An inventory of the internal dosimetric services
operating in each European state was also presented.
Information about measurement techniques and the
type of occupational internal exposures occurring by
country was supplied by the contact-persons; other
relevant information about individual monitoring
requirements (approval of services, accreditation of
laboratories, legal aspects, dose record keeping, etc.)
was also included in the report.
A collaboration was carried out with other
Internal Dosimetry Projects in Europe; for instance,
the OMINEX(3) projects (some UK internal dosi-
metry services agreed to share with EURADOS the
information they supplied to OMINEX) and the
‘Uranium and Thorium measurements related to
internal exposures’ Project(4) supported by European
Commission and coordinated by GSF (Germany).
CONCLUSIONS OF THE EURADOS
HARMONISATION STUDY
Internal doses cannot be measured directly. The
quantities adopted(5) to express the doses received
from intakes of radionuclides for radiological
protection purposes are the effective dose E (Sv)
and the equivalent dose HT (Sv) in tissue or organ
T. The dose coefficient e(g)j (Sv Bq
1) or committed
effective dose per unit of intake for radionuclide j by
ingestion or by inhalation is used to determine the
committed effective dose E50 (Sv) from an estimated
intake; for occupational exposures, the period of
time over which the committed effective dose is
assessed is 50 y.
The fraction of intake that remains in the body
(activity obtained by direct measurement methods)
or that is excreted from the body (evaluated by
indirect methods) at a time t after the intake depends
on the radionuclide, its chemical and physical forms,
the route and the moment (t) of intake. In case of
inhalation of radionuclides, the dose can also be
inferred by the measurement of airborne activity
concentration.
Workers undertaking tasks with the risk of
internal exposure must be included in individual
monitoring programmes for assessment of the
activity retained in or excreted from the body. Type
of technique (direct/indirect) and frequency of
measurements are established after the complete
characterisation of the potential intakes of the
radionuclides present at the workplace.
The first conclusion taken from the Harmoni-
sation Action is related to the type of internal
exposures. Many workers monitored by the services
included in the EURADOS study, undertake work
in Nuclear Power Plants, research centres and in the
medical field. Other workplaces with risk of internal
contamination are non-nuclear industry facilities,
nuclear fuel cycle laboratories and installations
undergoing decommissioning. In a small number of
cases monitoring of persons exposed to depleted
uranium was also reported.
Intakes of radionuclides can be determined by
either direct or indirect measurement methods.
There are more workers assessed for internal
exposures using direct methods [whole-body
counting (WBC) or organ counting by gamma
spectrometry] as compared with the number of
persons exposed and evaluated using indirect
techniques [determination of activity in excreta and
personal air samplers (PAS) and static air samplers
(SAS) monitoring]. Each type of measurement has
advantages and disadvantages; in vivo (direct)
counting offers the possibility of a rapid and
convenient estimation of the activity of the
radionuclide in the body, but suffers from important
calibration uncertainties, especially for low-energy
(X-ray and gamma-ray) photons. In vitro measure-
ments of activity in biological samples require the use
of a radiochemical analytical laboratory. All these
special features were considered in the EURADOS
study.
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DIRECT TECHNIQUES: IN VIVO
EVALUATION OF GAMMA EMITTERS
RETAINED IN THE BODY
The direct technique most commonly used to mon-
itor workers in Europe is WBC for in vivo determina-
tion of the activity of gamma emitters in total-body.
The detection of radioiodine in thyroid is required
for research and medical exposures; the assessment
of the activity of radionuclides in lungs is generally
associated with the exposure to Actinides (americium
and uranium, also plutonium). Other techniques are
available in a few facilities, for example the detection
of Actinides in liver or in bone, wound counting and
in vivo monitoring of beta emitters.
Whole-body counting: in vivo determination of
gamma emitters in total-body
The sample of in vivo laboratories collaborating
with EURADOS (63 whole-body counters from
52 internal dosimetry services) is representative of
the direct methods applied in Europe for the evalu-
ation of retained activity in the body after internal
exposures. Five mobile units, 30 detector systems
inside shielded room and 28 equipments with no
shielded room were reported.
Harmonisation in relation to materials and size of
room was found to exist in relation to the shielded
rooms constructed in 50% of in vivo facilities. The
aim is to reduce the background radiation and to
decrease the limits of detection (maximum
sensitivity). A typical European WBC would consist
of a room constructed with walls of 16 cm of steel
(outer shield), lined with 4 mm of Pb (inner shield)
and Cu or Cd. This reference facility would meet
recommendations established in the ICRU 69(6)
publication. Some laboratories were constructed
with concrete (30–70 cm) or iron (few instances)
instead of steel walls.
Different detector–subject arrangements are
available in WBC determinations. The counting
geometry selected by the facility usually looks for
the performance of measurements making maximum
efficiency accessible. Bed geometry (scanning and
stationary) is the most widely used configuration,
with chair geometry as an alternative arrangement,
and the standing-up counting geometry being
selected for quick monitoring.
The majority (53%) of European WBC facilities
use thick NaI(Tl) detectors (status 2001) for the
determination of gamma emitters in total-body
(either single or multidetector systems). A large
number of in vivo facilities installed high-purity Ge
(HPGe) detectors (excellent spectral resolution) with
different arrays.
In vivo calibration of whole-body monitoring
requires the use of anthropometric phantoms with
photon transmission properties equivalent of human
tissues. Plastic bottle phantoms, brick simulators
and BOMAB units are preferred. A set of radio-
nuclides is then introduced into the phantom with
uniform distribution of activity in the simulated
body. The EURADOS study shows that the mixture
of isotopes selected by services for WBC calibration
includes 137Cs and 60Co in most cases, with 109Cd,
139Ce, 203Hg, 113Sn and 88Y being chosen less
frequently. A group of facilities prefer the use of
multilines emitters as 152Eu or 133Ba. In a few
instances low-energy contribution is considered
(57Co or 241Am), and only 15% of the WBCs
perform total-body calibration with 40K.
The MDA is the indicator of the sensitivity of
in vivo detection systems. MDA represents the detec-
tion limit of the system expressed in terms of activity,
and is calculated using a blank person or a phantom
simulating the human body containing an expected
amount of 40K (4500 Bq for the standard man).
MDA mainly depends on background, counting effi-
ciency and counting time.
The EURADOS Catalogue registered the values
of MDA obtained by services for in vivo detection of
137Cs and 60Co in total-body. In general, there is a
good agreement with the data supplied by those
facilities using NaI(Tl) detectors for WBC. Differ-
ences were found in the cases of services using HPGe
detectors, with lack of agreement in the sensitivity
study. Optimisation of efficiency and sensitivity is
achieved by using a mixture of detector systems
(NaIþHPGe).
A typical European in vivo facility would use one
thick NaI(Tl) detector for WBC, in either bed or
chair geometry, for a counting time of 1200 s; the
sensitivity supplied by the system would be 60 Bq
of 137Cs and 60Co in total-body. Lowest MDA data
are found in a mixture of NaI(Tl) and HPGe detect-
ors inside a shielded room. Here, for a counting
time of 600 s, MDA values would meet the range
20–30 Bq. Quick monitoring is also performed with
NaI(Tl) detectors, for a standing-up counting
geometry and counting times of 1–2 min (MDA
obtained are 100–250 Bq).
Arrays using HPGe detectors, in either bed or chair
geometry, are used in a wide variety of working con-
ditions. The performance of in vivo determinations of
137Cs and 60Co in total-body with HPGe detectors
for a typical counting time of 1000 s was reported to
have a sensitivity in the range of 50–200 Bq of MDA.
Thyroid counting: in vivo determination of
131I and 125I
Thirty-eight in vivo facilities (44 thyroid systems)
collaborated with EURADOS in the harmonisation
study. In vivo determination of 131I (364.5 keV) is
typically carried out with one NaI(Tl) detector at an
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average distance of 10–15 cm from the thyroid area
(50% of laboratories). MDA range covers values
from 4 to 800 Bq, with a counting time range of
10–1800 s (typically 600 s). It was noted that HPGe
detector are used in a small number of facilities also.
Thirteen of the in vivo facilities included in the
catalogue determine 125I retained in the thyroid
gland. Those using semiconductor systems, HPGe
or low-energy Ge detectors, obtained values of
MDA 5 Bq of 125I (27 keV). In few instances
NaI(Tl) detectors are selected, 25 Bq of 125I being
the lowest MDA reported; in this case analysis was
carried out using the 27 keV (X ray) and 35 keV
(gamma ray) emissions of this radionuclide.
Lung counting
In vivo determination of radionuclides in lungs is in
general carried out for workers with risk of
inhalation of Actinides with long retention time in
lungs (U, Pu and 241Am oxides). The difficulty of this
type of measurements is related to the complex
detection of the low-energy photons (10–200 keV)
internally deposited in the body, going through
the torso tissues and reaching the detector. Eleven
laboratories participated in this part of the
EURADOS Catalogue, the majority are using
Ge detectors as lung counters. Lawrence Livermore
National Laboratory (LLNL) and Alderson
Phantoms are widely accepted for lung calibration;
no services reported using the Japanese Atomic
Energy Research Institute (JAERI) phantom.
There was general agreement of the use of overlay
chest plates with a composition of 50% muscle and
50% adipose for the efficiency study.
The assessment of the activity in lungs is carried
out in routine monitoring from in vivo measurements
of 241Am, 235U, 234Th/238U, 239Pu and 232Th, with
counting times covering the range 1200–3000 s. The
sensitivity of the detector system is in general
obtained for a typical chest wall thickness of 3 cm.
Lowest MDA values (3–5 Bq) are obtained in the
determination of 235U (186 keV) in lungs (assessment
of the intake of enriched uranium). The MDAs
reported by services for in vivo determination of
241Am are in the range 4–8 Bq. Forty-five bequerels
of 234Th is the value associated with the sensitivity
of the detection system for the evaluation of 238U in
lungs (natural uranium).
INDIRECT TECHNIQUES: IN VITRO
EVALUATION OF THE ACTIVITY
EXCRETED FROM THE BODY
Forty-three in vitro laboratories participated in
the EURADOS study answering the 2002-
Questionnaire with information about the indirect
techniques used for the determination of internal
exposures at workplace. The more important con-
clusions about methodology and performance fea-
tures are presented as follows.
In vitro measurements of Actinides in excreta
(19 laboratories)
Alpha spectrometry is the technique most commonly
used by services for in vitro measurements of
Actinides in excreta. ICP/MS (inductively coupled
plasma mass spectrometry), high sensitivity
technique for the measurement of uranium and
thorium isotopes in urine, was available in three
facilities included in the EURADOS Catalogue
(2001), but no further information was supplied
about its performance or procedures. Other indirect
determinations of Actinides are carried out by
Fluorimetry, Kinetic Phosphorescence Analyser
(KPA) for uranium measurements, liquid
scintillation counting (LSC) (application to alpha
emitters), LABSOCS (Laboratory Sourceless Object
Calibration Software) and Waterscintillator, and
Gamma spectrometry.
Urine analysis of 24 h samples are performed by
Alpha spectrometry with typical MDAs in the range
of 0.1–0.5 mBq d1, with the counting time varying
from 220 000 to 430 000 s. A second group of labor-
atories reported MDA values in the range of
0.1 (500 000 s) to 0.5 (250 000 s) mBq l1 of Actinides
in urine. MDA values close to 0.1 mBq d1 are
recommended for the determination of Actinides in
urine. Passivated Implanted Planar Silicon (PIPS)
detectors are widely used in Alpha spectrometry.
Normalisation of creatinine content in urine was
only reported by two facilities. With reference to the
collection of faecal samples, 3 d faecal samples or
single-voiding are alternatives to 24 h samples in few
instances. The radiochemical Actinides separation
methods reported in some cases are extraction
chromatography and ion exchange chromatography.
In vitro determinations of pure beta emitters in
excreta (25 laboratories)
LSC (19 facilities) and proportional counters
(six laboratories) are the techniques used by services
for in vitro determination of beta emitters in excreta.
Typical radionuclides to be evaluated are 3H and
90Sr with 14C, 32P, 35S, 89Sr, 90Y, 125I and 45Ca also
being of interest.
Agreement can be seen in relation to the volume of
the sample required to measure 90Sr in urine (24 h
samples), but there is little harmonisation for the
determination of 3H in urine, with volumes varying
from 10 ml to 1 litre. The preparation of the source
for measurement (radiochemical separation, etc.)
vary considerably among the laboratories. The
sensitivity data reported by services show that
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typical MDAs are in the interval 25–250 Bq l1 of 3H
in urine using LSC technique; lowest MDA reported
is 1.2 Bq l1 for a counting time of 100 000 s.
Gamma spectrometry determinations
(17 laboratories)
HPGe detectors are widely used by services for
in vitro determinations of gamma emitters in excreta.
Ge(Li) and NaI(Tl) detectors are also employed. The
volume of urine and faeces being collected covers a
24 h sampling period. The MDA values obtained
by laboratories are 1 Bq for 137Cs, 60Co and 131I.
Differences are found in the counting time selected
by facilities with resulting MDAs varying from 0.01
to 1 Bq for typical gamma emitters.
PAS/SAS monitoring
PAS implies the collection of a sample representative
of the activity concentration in the air inhaled by
the worker. This allows an estimate of the intake
of some typical radionuclides. To know or to make
realistic assumptions about the particle size distri-
butions in the inhaled material is required for the
correct estimation of internal exposures.
SAS are commonly used to monitor workplace
conditions, but can underestimate concentrations in
air in the breathing zone of the worker [ICRP 78(7)].
Thirteen European laboratories (eight SAS and
five PAS) included in the EURADOS Catalogue
perform PAS/SAS monitoring. Some alpha, beta or
gamma emitters can be evaluated by PAS/SAS
measurements, particularly 131I, uranium, thorium
and plutonium isotopes. The results are not always
used for individual dose evaluation. Different MDA
values are obtained in each laboratory depending
on the radionuclide and type of monitoring selected.
An important contribution was the information
collected from UK Services, who agreed to share
with EURADOS the information supplied to the
OMINEX Project. A typical MDA value supplied
for PAS monitoring, gross alpha is 0.02 Bq which
applies to U, 232Th, 228Th and Pu-alpha.
ASSESSMENT OF INTERNAL DOSES
IN EUROPE
The doses received by workers travelling and
working at different European facilities have to be
assessed in a similar way by internal dosimetric
services. The design of individual monitoring pro-
grammes to evaluate occupational internal expos-
ures depends on the annual dose limit in place. Of
the 26 participating countries registered in the
EURADOS Catalogue, 60% have implemented an
annual dose limit of 20 mSv, and 40% established
a limit of 100 mSv in 5 y with a maximum dose of
50 mSv y1. In this last instance, an operating value
of 20 mSv as an annual average limit for 5 y was
reported in some countries.
With reference to the record keeping of dose
evaluations, 14 out of 24 countries have National
Record of Doses (status in 2001). It is highly recom-
mended that in the future each country sets up
a central location for record keeping of internal
doses. It is further proposed here that a Europe wide
Record of Individual Doses be set up in the future.
The software available to European services for
internal dose assessments (status 2001) includes the
codes IMBA (Integrated Modules for Bioassay
Analysis), LUDEP (Personal computer Program
for Calculating Internal Doses), IMIE (Individual
Monitoring of the Internal Exposure), Mondal/
Moldes, MIRD (Medical Internal Radiation Dose)
software, INDAC (Internal Dose Assessment Code),
Cindy, Remedy and Retex. It is important to remark
that not all of them operate with the latest ICRP
recommendations as set out in the EU Directive
96/29. An important piece of work has been carried
out by the IDEAS(8) Project which includes the
outcome of a Dose Intercomparison exercise. An
objective of the IDEAS Project is the development
of general guidelines for the estimation of committed
dose from incorporation monitoring data.
In relation to the internal doses reported by
services, a European reference level of ‘lowest
reported dose’ of 0.1 mSv could be established as
an average value of the data collected in the
EURADOS Catalogue, but currently harmonisation
does not exist. Some internal dosimetry laboratories
calculate all doses obtained from measured activity
above MDA. Upper limit of minimum reported dose
is 2 mSv. The same lack of agreement occurs in the
Investigation Level (IL) where European countries
selected very different IL, from 0.1 to 6 mSv.
A brief summary of legal aspects, other matters
and requirements employed in the management and
operation of internal dosimetric services of some
selected countries are reported as follows.
Sweden
EU Directive is implemented in Sweden since 1998
(SSI FS 1998:5/2000:10 Guide). The National Regu-
latory Body is SSI (Swedish Radiation Protection
Authority) Institute. Scandinavian countries (Norway,
Sweden, Denmark and Finland) are usually very well
coordinated and harmonised in dosimetric matters.
With reference to the assessment of internal
exposures, monitoring programmes in Sweden are
established for three worker categories: Group
of reference, Group of high risk of intake and
Incidents with known intake. Twelve institutes are
performing internal dosimetry (NPP, NFC, medical
field, research and decommissioning), and no legal
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approval of services is required. WBC monitoring
shall be performed according to the documented
procedure that is approved by SSI (SSI 2000:10).
The Radiation Protection Authority in Sweden is
capable of evaluating internal doses, but the
responsibility for that is, under normal conditions,
given to services. Dose Recording Level is 0.25 mSv
(minimum dose recorded by services) but the
report to National Dose Register is carried out if
E50> 1 mSv. For doses E50> 5 mSv, immediate
communication of the incident to SSI is required.
Germany
Implementation of EU Directive in 2001 (Radiation
Protection Ordinance). The term ‘Regulatory Body’
in Germany applies to federal and state authorities
but the Accreditation of laboratories is carried
out by state government. The more relevant guide-
lines for individual monitoring are ‘Physical Rad.
Monitoring (methods, intervals, action levels, etc.)’,
‘Determination of body doses caused by internal
exposure’ and ‘Performance requirements for
dosimetry laboratories’.
There are 25 institutes performing internal dosi-
metry in Germany and one National Dose Register.
Monitoring programmes of workers for internal
exposures have to ensure the detection of 1 mSv as
annual dose. All the doses are reported, and the
Investigation Dose Level in Germany is 6 mSv.
Hungary
Hungary is a new EU member state and has already
implemented EU Directive. The Ministry of Health
acts as Regulatory Body and the setting up of a
National Dose Register is in progress. The laborat-
ory performing the monitoring of internal exposure
shall be accredited; there are three accredited
internal dosimetry services in Hungary. One is
legally commissioned for country record keeping.
Important institutes in Hungary for internal dosi-
metry matters are the National Research Institute
for Radiobiology and Radiohygiene (NRIRR),
which performs in vivo and in vitromeasurements
(monitoring of workers of Nuclear Power Plants,
Nuclear Fuel Cycle, research and medical field),
and the Atomic Research Institute (KFKI), with
the capability of in vivo monitoring for the whole
centre and upon request for other institutions as
well as for the public. The lowest reporting dose in
Hungary is 0.1 mSv and the IL is 6 mSv.
SUMMARY
An important network of services from 26 countries
has been established for the harmonisation of
individual monitoring of internal exposures. The
information collected from 73 internal dosimetry
services provides an overview of the capability and
actual status of techniques, methods and available
tools for the assessment of internal exposures
in Europe. The EURADOS Catalogue was pub-
lished(2), thus sharing with the dosimetric commun-
ity the information collected.
Harmonisation is a reality in many aspects of
internal dose assessments, but not in the overall pro-
cess. Looking into the future, it is highly recommen-
ded the focus be placed on the lack of dosimetric
tools and (methods used by many services) codes in
many services to calculate effective doses using the
latest ICRP models and effective regulation. The per-
formance of a reference European internal dosimetry
service has to guarantee adequate sensitivity of the
measuring techniques and the accuracy of the results
of Committed Effective dose. There is still a long way
to go. As final proposal here it is suggested that a way
forward might be the setting up of an European
Accreditation Process for European Laboratories
dealing with the assessment of internal exposures.
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